Related Experiment Video
Updated: Mar 6, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
RUNX3 and p53: How Two Tumor Suppressors Cooperate Against Oncogenic Ras?
Jung-Won Lee1, Andre van Wijnen2, Suk-Chul Bae3
1Department of Biochemistry, School of Medicine, and Institute for Tumor Research, Chungbuk National University, Cheongju, 28644, South Korea.
Abstract:
RUNX family members play pivotal roles in both normal development and neoplasia. In particular, RUNX1 and RUNX2 are essential for determination of the hematopoietic and osteogenic lineages, respectively. RUNX3 is involved in lineage determination of various types of epithelial cells. Analysis of mouse models and human cancer specimens revealed that RUNX3 acts as a tumor suppressor via multiple mechanisms. p53-related pathways play central roles in tumor suppression through the DNA damage response and oncogene surveillance, and RUNX3 is involved in both processes. In response to DNA damage, RUNX3 facilitates p53 phosphorylation by the ATM/ATR pathway and p53 acetylation by p300. When oncogenes are activated, RUNX3 induces ARF, thereby stabilizing p53. Here, we summarize the molecular mechanisms underlying the p53-mediated tumor-suppressor activity of RUNX3.
Insights
RUNX3 acts as a tumor suppressor by regulating p53 pathways. It enhances the DNA damage response and oncogene surveillance, crucial for preventing cancer development.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- RUNX family proteins are critical in development and cancer.
- RUNX1 and RUNX2 specify hematopoietic and osteogenic lineages.
- RUNX3 is involved in epithelial cell lineage determination.
Purpose of the Study:
- To elucidate the molecular mechanisms of RUNX3's tumor-suppressor activity.
- To understand RUNX3's role in p53-mediated pathways.
- To investigate RUNX3's function in DNA damage response and oncogene surveillance.
Main Methods:
- Analysis of mouse models.
- Examination of human cancer specimens.
- Molecular pathway analysis.
Main Results:
- RUNX3 functions as a tumor suppressor through multiple mechanisms.
- RUNX3 facilitates p53 phosphorylation via ATM/ATR in response to DNA damage.
- RUNX3 induces ARF to stabilize p53 during oncogene activation.
Conclusions:
- RUNX3 plays a significant role in tumor suppression.
- RUNX3's activity is closely linked to p53-mediated processes.
- RUNX3 is a key regulator in maintaining genomic stability and preventing neoplasia.
More Related Videos
10:13A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
Published on: July 3, 2013
04:56Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Related Concept Videos
The Ras Gene
Ras is a...
Abnormal Proliferation
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...